Effect of Age, Polymicrobial Disease, and Maternal HIV Status on Treatment Response and Cause of Severe Pneumonia in South African Children: a Prospective Descriptive Study
Overview
Authors
Affiliations
Background: HIV-related pneumonia is the main cause of paediatric hospital admissions in southern Africa. We aimed to measure predictors of treatment failure and the cause of non-responsive pneumonia in children admitted to hospital with severe pneumonia in Durban, South Africa.
Methods: We investigated 358 children aged 1-59 months who presented with WHO-defined severe or very severe pneumonia. Children were recruited irrespective of HIV status and started on a standard antimicrobial regimen of benzylpenicillin and gentamicin. All infants also received high-dose trimethoprim-sulfamethoxazole. The primary outcome measure was treatment failure at 48 h.
Findings: 242 (68%) children were HIV infected, 41 (12%) HIV exposed, uninfected, and 75 (21%) HIV uninfected. Failure to respond by 48 h was predicted by age under 1 year (adjusted odds ratio 6.38, 95% CI 2.72-14.91, p<0.0001), very severe disease (2.47, 1.17-5.24, p=0.0181), HIV status (HIV infected 10.3, 3.26-32.51; HIV exposed, uninfected 6.02, 1.55-23.38; p=0.0003), and polymicrobial disease (one organism 2.06, 1.05-4.05; two organisms 10.75, 4.38-26.36; p<0.0001) on logistic regression analysis. All children with three organisms failed treatment. 72/110 treatment failures had at least two organisms isolated. Three of nine HIV-exposed, uninfected infants, 29/74 HIV-infected, but no HIV-uninfected infants who failed study therapy had Pneumocystis jirovecii pneumonia.
Interpretation: For children younger than 1 year, the WHO guidelines are inadequate and need to be revised since both HIV-infected and HIV-exposed, uninfected infants had more treatment failures than did HIV-uninfected infants. Polymicrobial disease is an important reason for treatment failure, and we need to identify rapid low-cost diagnostic methods to assist clinicians.
Mann A, Aumend C, Crull S, OConnell L, Osagie E, Akhigbe P Res Sq. 2024; .
PMID: 39149457 PMC: 11326420. DOI: 10.21203/rs.3.rs-4720457/v1.
Mann A, OConnell L, Osagie E, Akhigbe P, Obuekwe O, Omoigberale A Microbiol Spectr. 2023; 11(4):e0087123.
PMID: 37428077 PMC: 10434123. DOI: 10.1128/spectrum.00871-23.
The hard part we often forget: providing care to children and adolescents with advanced HIV disease.
Frigati L, Gibb D, Harwell J, Kose J, Musiime V, Rabie H J Int AIDS Soc. 2023; 26(3):e26041.
PMID: 36943761 PMC: 10029994. DOI: 10.1002/jia2.26041.
Jackson C, Frank D, Robertson C, Ir D, Kofonow J, Montlha M mBio. 2022; 13(5):e0122922.
PMID: 36073815 PMC: 9600264. DOI: 10.1128/mbio.01229-22.
Jalbert E, Ghosh T, Smith C, Amaral F, Mussi-Pinhata M, Weinberg A Front Immunol. 2022; 13:960313.
PMID: 36032106 PMC: 9411519. DOI: 10.3389/fimmu.2022.960313.